Sex, age and HIV-1 status influence complement activation against SARS-CoV-2 mRNA vaccine Spike protein
- 1University of Pittsburgh
Abstract
Regulation of complement activity influences immunity and clinical outcomes of SARS-2 CoV-2 infections. Here we investigated antibody responses to SARS-CoV-2 vaccination and complement activity in men (age 36 to 86) and women (age 39 to 83) with (MWH, WWH) and without (MWOH, WWOH) HIV-1. Antibody responses in WWH were lower than in MWH. WWH also had negligible change in blood C3a post-immunization, whereas MWH had greater C3a levels. We investigated the levels of C5, C5a, C1-INH, factor H, and circulating immune complex-C1q (CIC-C1q) binding to understand the regulation of complement activity. We found that C1-INH and anti-S antibody levels were driving the differences in C3 convertase activity in MWH. No significant differences were found between C5 and C5a in both cohorts, suggesting that C5 convertase is not being activated. These results show that biological sex may impact SARS-CoV-2 immune responses and highlights the need for further investigation.
Related
- Post-exposure vaccination with an adjuvanted protein subunit vaccine, but not BCG, protects mice and guinea pigs against M. tuberculosis
- Early detection of immunoglobulin A against a vaccine backbone protein enables fast, durable, and objective identification of individuals vaccinated against Ebola virus
- Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite protein
- Wide-angled proteomics in giant cell arteritis reveals complement pathway activation
- Monocyte-associated C1q upregulation and complement activation contribute to vascular endothelial and multi-organ injury in severe dengue
BibTeX
@misc{tuttle2026hiv1,
title = {{Sex, age and HIV-1 status influence complement activation against SARS-CoV-2 mRNA vaccine Spike protein}},
author = {D. J. Tuttle and P. Tien and N. P. Sluis-Cremer and R. B. Mailliard and C. R. Rinaldo and E. T. A. Marques},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.04.26366940},
url = {https://www.medrxiv.org/content/10.64898/2026.11.04.26366940v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Sex, age and HIV-1 status influence complement activation against SARS-CoV-2 mRNA vaccine Spike protein
AU - D. J. Tuttle
AU - P. Tien
AU - N. P. Sluis-Cremer
AU - R. B. Mailliard
AU - C. R. Rinaldo
AU - E. T. A. Marques
PY - 2026
DA - 2026/11/04
PB - medRxiv
DO - 10.64898/2026.11.04.26366940
UR - https://www.medrxiv.org/content/10.64898/2026.11.04.26366940v1
AB - Regulation of complement activity influences immunity and clinical outcomes of SARS-2 CoV-2 infections. Here we investigated antibody responses to SARS-CoV-2 vaccination and complement activity in men (age 36 to 86) and women (age 39 to 83) with (MWH, WWH) and without (MWOH, WWOH) HIV-1. Antibody responses in WWH were lower than in MWH. WWH also had negligible change in blood C3a post-immunization, whereas MWH had greater C3a levels. We investigated the levels of C5, C5a, C1-INH, factor H, and circulating immune complex-C1q (CIC-C1q) binding to understand the regulation of complement activity. We found that C1-INH and anti-S antibody levels were driving the differences in C3 convertase activity in MWH. No significant differences were found between C5 and C5a in both cohorts, suggesting that C5 convertase is not being activated. These results show that biological sex may impact SARS-CoV-2 immune responses and highlights the need for further investigation.
ER -